Food Science of Animal Resources (한국축산식품학회지)

Korean Society for Food Science of Animal Resources (한국축산식품학회)
권호 표지
DOI QR코드

DOI QR Code

Utilization of Probiotic-Derived Extracellular Vesicles as Postbiotics and Their Role in Mental Health Therapeutics

  • Jihyeon Baek (Department of Food Science and Biotechnology, College of Life Science and Biotechnology, Dongguk University) ;
  • Suyeon Lee (Department of Food Science and Biotechnology, College of Life Science and Biotechnology, Dongguk University) ;
  • Jinho Lee (Department of Food Science and Biotechnology, College of Life Science and Biotechnology, Dongguk University) ;
  • Jihyun Park (Department of Food Science and Biotechnology, College of Life Science and Biotechnology, Dongguk University) ;
  • Esther Choi (Department of Food Science and Biotechnology, College of Life Science and Biotechnology, Dongguk University) ;
  • Seok-Seong Kang (Department of Food Science and Biotechnology, College of Life Science and Biotechnology, Dongguk University)
  • Received : 2024.07.18
  • Accepted : 2024.09.23
  • Published : 2024.11.01
Download PDF
⟨ Previous Next ⟩

Abstract

As consumers become more interested in healthier lifestyles, the global functional food market is expanding. Probiotics have gained attention because of their numerous health benefits to the host and may even treat various pathological conditions. Probiotics interact with host cells, and particularly, probiotics-derived extracellular vesicles (PEVs) are key factors in the health benefits of probiotics. Additionally, extracellular vesicles are nano-scaled lipid-bilayer particles that carry various biological molecules, indicating potential as new postbiotics that can provide the same health benefits as probiotics while complementing the side effects associated with probiotics. The importance of mental health care is becoming increasingly prominent considering societal conditions, such as the recent aging population and the coronavirus disease 2019 pandemic. However, the response to mental health issues among modern individuals is insufficient, and there is a need for the development of new personalized treatments to overcome the limitations of current mental health therapies. PEVs have various physiological functions, including mediating cellular communication in the central nervous system, which indicates associations among mental disorders. Therefore, we focused on the beneficial effects of PEVs on the brain and mental health. Recent research has shown that PEVs can adjust the expression of brain-derived neurotrophic factors in vitro and in vivo, demonstrating antidepressant and cognitive function improvement effects. This suggests that PEVs have potential as therapeutic agents for improving mental health and treating brain disorders. Based on this, we review these findings and present the beneficial effects of PEVs on mental health and the challenges that need to be addressed.

Keywords

Introduction

Mental health disorders, such as depression and anxiety, are common among adults worldwide. Depression, which is characterized by a consistently low mood, is a complex mental illness influenced by genetics, brain chemical abnormalities, psychosocial stressors, and traumatic experiences (Bistas and Tabet, 2023). An increasing number of studies have shown the relationship between gut microbiota and mental health through the brain-gut axis communication (Clapp et al., 2017; Xiong et al., 2023). Gut microbiota dysbiosis negatively impacts the maintenance of mental health and promotes the progression of mental illness. A healthy and balanced gut microbiota composition is influenced by several factors, including diet, age, and stress levels (Abdul-Aziz et al., 2016).

Probiotics are widely recognized for their influence on the gut microbiota, playing a role in regulating the composition and structure of the gut microbiota. Moreover, an extensive number of studies have shown that probiotics supplementation significantly improves psychological symptoms of mental illness (Amirani et al., 2020). However, despite their benefits, probiotics have certain risks, for example, antibiotic resistance and potential infections in individuals with immunocompromised conditions (Nataraj et al., 2020). Postbiotics, which have emerged as alternatives to probiotics, are soluble substances secreted or released by bacteria during lysis and include enzymes, peptides, cell wall components, polysaccharides, and cell surface proteins, as well as metabolites produced by bacterial growth (Nataraj et al., 2020). In addition, recent evidence suggests that extracellular vesicles (EVs) derived from bacteria may also be classified as postbiotics because of their protective abilities against the development and progression of diseases (Yang et al., 2022). In this review, we mainly focus on EVs from probiotics as potential therapeutic agents for mental illnesses. Additionally, we discuss evidence suggesting that probiotics-derived EVs (PEVs) alleviate the symptoms of Alzheimer’s disease.

Probiotics

An aging population and the global increase in chronic health conditions are steering consumers toward adopting healthier lifestyles. This has led to increased awareness and interest in functional foods (Baker et al., 2022; Lillo-Pérez et al., 2021; Palanivelu et al., 2022). In particular, probiotics represent the primary focus in functional food production because of their significant health potential (Begum et al., 2017). The global probiotics market, focusing solely on the human end-use segment, is projected to exceed an anticipated value of approximately USD 5.5 billion by 2032 (Lee et al., 2024). Probiotics are defined by the Food and Agriculture Organization of the United Nations (FAO) and the World Health Organization (WHO) as “Live microorganisms which when administered in adequate amounts confer a health benefit on the host.” Probiotics are live microorganisms that differ from prebiotics, which are selectively used to confer health benefits, and from postbiotics, which are non-living microbial products or substances that provide advantageous effects to the host (Ji et al., 2023). Probiotics primarily include lactic acid bacteria (LAB), with notable representatives, such as Bifidobacterium, Lactobacillus, Leuconostoc, and Pediococcus (Son et al., 2018). LAB are generally recognized as safe owing to their inherent presence in fermented foods, such as kimchi, cheese, and jeotgal (Castellano et al., 2017). Every genus encompasses numerous species, and within each species, there exist a multitude of strains. The health benefits associated with probiotics are typically regarded as being specific to each strain (Ji et al., 2023). Probiotics have the potential to modify the composition of the gut microbiota, vie with pathogens for nutrients and attachment sites on the intestinal lining, fortify the integrity of the intestinal barrier, and regulate the immune system (Wang et al., 2021; Wieërs et al., 2020). In particular, Lacticaseibacillus rhamnosus GG, isolated from the human intestine, is one of the most effective probiotics due to its ability to survive in the acidic stomach and colonize the intestine, and it is still widely used as a commercial strain (Capurso, 2019). In addition to providing gut-related health benefits, probiotics may also affect brain function, cognition, and behavior through interactions between gut microbes and the central nervous system (CNS; Gambaro et al., 2020). The bidirectional connection between the microbiota−gut−brain axis is based on metabolic, neural, and immunological pathways that include the vagal nerve, the hypothalamic−pituitary−adrenal axis, and the production of bacterial metabolites (Góralczyk-Bińkowska et al., 2022; Zagórska et al., 2020). Because probiotics positively alter the gut microbiota and produce neuroactive and neuroendocrine molecules that act on the CNS based on the microbiota−gut−brain axis, they can serve as a foundation for the treatment of psychiatric disorders (Gambaro et al., 2020; Tong et al., 2020). Although probiotics offer health benefits as a medicine for mental disorders, the WHO and the FAO have noted that the use of living microbial cells in probiotics may raise safety concerns and potential side effects (Yeşilyurt et al., 2021). Probiotics side effects include systemic infections and harmful metabolic activities, and common issues are gastrointestinal disorders (diarrhea, nausea, gas, dyspepsia, and abdominal pain; Zielińska et al., 2018). There is research indicating that using derivatives or byproducts of viable microorganisms inactivated through diverse techniques can mitigate safety concerns and lower the infection risk in individuals with increased intestinal permeability and a compromised immune system (Collado et al., 2019).

Postbiotics

Postbiotics are considered a promising alternative supplement to address potential risks associated with probiotics (Chaudhari and Dwivedi, 2022; Żółkiewicz et al., 2020). In 2021, the International Scientific Association for Probiotics and Prebiotics (ISAPP) defined postbiotics as “a preparation of inanimate microorganisms and/or their components that confers a health benefit on the host” (Salminen et al., 2021). Possible pathways for the transmission of health benefits through postbiotics are similar to those of probiotics (Hernández-Granados and Franco-Robles, 2020; Yeşilyurt et al., 2021). Postbiotics refer to metabolic byproducts, including organic acids, short-chain fatty acids, and polysaccharides or bioactive compounds such as lipoteichoic acid and peptidoglycan, as well as DNA generated by living microorganisms during growth or fermentation (Balthazar et al., 2022; Liu et al., 2023; Yan et al., 2024). Although the precise mechanisms by which postbiotics exert their beneficial effects on the host have not been well understood, one of the most well-documented effects is their immunomodulatory potential. For instance, several postbiotic molecules, such as lipoteichoic acid and peptidoglycan in the cell wall structure, can directly interact with Toll-like receptors or nucleotide-binding oligomerization domain-like receptors, modulating immune functions by regulating intracellular signaling pathways, including the nuclear factor-κB, mitogen-activated kinase pathways and PI3K/Akt-mediated pathways. Moreover, postbiotics not only interact with host cells, but may also affect microbial communities, which may represent indirect mechanisms of action (Jastrząb et al., 2021). Furthermore, as non-living substances and because they do not replicate in the gut, postbiotics offer a safer option than probiotics for individuals with a compromised immune system or critical illness (Ailioaie and Litscher, 2021). Postbiotics offer the advantage of being stored at room temperature, simplifying transportation and ensuring cell counts remain constant (Piqué et al., 2019; Yan et al., 2024). Their functional attributes result in improved stability, texture, and taste compared to probiotics, enhancing the physicochemical and sensory qualities of the product. As a result, they can be incorporated as functional additives to enhance product quality (Barros et al., 2020). The increasing research on the physiological benefits of PEVs suggests that EVs could serve as potential novel postbiotics (Krzyżek et al., 2023; Liang and Xing, 2023; Xie et al., 2023).

Characteristics of Extracellular Vesicles

Current research indicates that the health-beneficial activity of probiotics is mainly regulated by the production of EVs (Krzyżek et al., 2023). Recent studies propose that EVs could emerge as the postbiotics of the future, carrying potential health advantages (Xie et al., 2023). EVs are nano-scaled lipid-bilayer particles secreted by virtually every type of living cell, including plant cells, mammalian cells, bacteria, and probiotics (Kameli et al., 2021; Krzyżek et al., 2023; Morishita et al., 2021). EVs are classified into various types based on their sizes, origins, and function, for example, exosomes, ectosomes, apoptotic bodies, and oncosomes (Kong et al., 2023). Among these, exosomes are particularly well studied and typically fall within the nano-size range of 20–300 nm (Kong et al., 2023; Mandelbaum et al., 2023)

Probiotics, which are mostly Gram-positive bacteria, have a complex process for the biogenesis of EVs because of the presence of a thick peptidoglycan layer (Fig. 1; Liu et al., 2022). Previously, some non-mutually-exclusive hypotheses have been proposed about the mechanism by which EVs are released from the thick cell walls of Gram-positive bacteria. First, the release of the EVs from the cytoplasm membrane generates turgor pressure, prompting the extrusion of EVs through the cell wall. Additionally, specialized protein channels in the peptidoglycan layer may help guide EVs out of the cell (Brown et al., 2015). Finally, endolysin degrades the peptidoglycan layer, causing bubbling cell death and leading to the formation of cytoplasmic membrane vesicles (CMVs). These CMVs refer to EVs produced by Gram-positive bacteria. CMVs can carry various cargo, including cytoplasmic membrane proteins, RNA, chromosomal DNA, endolysins, and virulence factors (Bose et al., 2020; Muñoz-Echeverri et al., 2024; Suri et al., 2023).

CSSPBQ_2024_v44n6_1252_4_f0001.png 이미지

Fig. 1. Biogenesis of EVs in Gram-positive bacteria. Several exclusive hypotheses explain the mechanism for EVs release, including turgor pressure pushing EVs through the cell wall, specialized protein channels facilitating EVs exit, and endolysin degrading the peptidoglycan layer, leading to cytoplasmic membrane vesicles formation. This figure is created using the image tool available online from BioRender.com. EVs, extracellular vesicles.

EVs contain various molecules, such as microRNAs (miRNA), proteins, lipids, and metabolites, that can be functionally delivered between cell types and across species (Gandham et al., 2020). Genetic information carried by EVs, like mRNA and miRNA, can be safely transferred from outside the cell into the cell, where it can regulate gene expression or send signals within the cell (Mulcahy et al., 2014). Because miRNAs have complex regulatory networks, they can commute between different cells to control the rate of translation and transcription (O’Brien et al., 2018). As a result, EVs can act as signal molecules to mediate intercellular communication, transfer cargo from donor cells to recipient cells (Lee et al., 2023; Li et al., 2023), and impact physiological and pathological responses. In addition, EVs participate in antigen presentation, neuronal communication, immune modulation, metastasis, interspecies/intraspecies/interkingdom communication, stress tolerance, and horizontal gene transfer (Hosseini-Giv et al., 2022; Lee et al., 2023). According to recent research, PEVs can serve as a new communication pathway between the host and microbe (Morishita et al., 2021). PEVs can permeate the blood−brain barrier (BBB) and other tissue barriers (Guo et al., 2024). For example, fluorescent-labeled exosomes administered intranasally to mice were located in the brain (Zhuang et al., 2011). Furthermore, it has been observed that CMVs derived from Lactiplantibacillus plantarum have the capability to traverse the BBB and undergo internalization by neurons (Xie et al., 2023). Another mechanism by which EVs can penetrate the brain is through the vagus nerve (Bleibel et al., 2023). In mice administered with EVs via oral gavage, the absorption of EVs increased, whereas in mice that underwent vagotomy, EVs’ absorption was inhibited (Lee et al., 2020). This ability demonstrates that EVs may be useful for drug delivery. Research findings suggest that PEVs promote gut health by modulating gut microbiota and regulating inflammatory responses in the intestine (Tong et al., 2021; Table 1). Moreover, PEVs offer a broader range of health benefits beyond promoting gut health (Fig. 2). For instance, PEVs have been shown to inhibit the growth of liver cancer cells and induce apoptosis (Behzadi et al., 2017), as well as alleviate conditions such as food allergies and atopic dermatitis (Kim et al., 2016; Kim et al., 2018). Another feature of PEVs is that they interact with immunological receptors on glial cells, leading to changes in brain function (Guo et al., 2024; Ma et al., 2021). As such, PEVs have various effects on the health of not only the intestine but also the whole body, and we have noted the effects of these various effects, especially on mental health.

Table 1. Various positive effects of PEVs on health

CSSPBQ_2024_v44n6_1252_5_t0001.png 이미지

PEVs, probiotics-derived extracellular vesicles.

CSSPBQ_2024_v44n6_1252_6_f0001.png 이미지

Fig. 2. Health benefits of PEVs. Several studies confirmed their beneficial effects on host health, such as maintaining intestinal barrier integrity, having anticancer activity, and improving physical disorders. This figure is created using the online image tool available from BioRender.com and Flaticon.com. PEVs, probiotics-derived extracellular vesicles.

Mental health is critically important to everyone, everywhere. Mental disorders are health conditions that are defined by dysfunctional thinking, mood, or behavior, which are associated with many problems that can include disability, pain, or death (Gamm et al., 2010). The recent rapid population aging and tremendous economic and political changes have contributed to and will continue to contribute to the prevalence and impacts of mental disorders (Hossain et al., 2020; Park and Kim, 2011). Additionally, the need for mental health care is on the rise due to the widespread confusion caused by the coronavirus disease 2019 (COVID-19) pandemic across the population in recent years (Hossain et al., 2020; Roy et al., 2020). However, according to the WHO, current mental health responses are insufficient and inadequate (WHO, 2022). Moreover, the mental health treatment field has its limitations and is prone to adverse effects, highlighting the need for novel, customized treatments (Johnson et al., 2023). Recent progress in research on PEVs has confirmed the potential for applying PEVs to enhance the treatment of mental disorders, and we would like to introduce this.

Potential as an Antidepressant 

Several studies have shown that the Lactobacillus-derived EVs reverse the expression of neurotrophic factors increased by glucocorticoids (GC), a class of stress hormones, in HT-22 cells.  Corticosterone is the primary stress hormone in mammals and a key GC in rodents (Silva et al., 2022). Furthermore, the brain-derived neurotrophic factor (BDNF) belongs to a family of neurotrophins that play an important role in the survival and differentiation of neuronal populations (Miranda et al., 2019). EVs derived from L. plantarum (Lp-EV) reversed GC-induced reduced expression of total Bdnf (tBdnf) and the BDNF splicing variants Bdnf1, Bdnf4, and Ngf. Moreover, Lp-EV treatment blocked GC-induced reduced expression of proBDNF (Choi et al., 2019). The siRNA-mediated knockdown of Sirt1 in HT-22 cells suggested that Sirt1 played an important role in Lp-EV-induced upregulation of Bdnf4 and cyclic AMP-responsive element-binding protein 1 (Creb1). This ultimately demonstrates that Lp-EV treatment increases Sirt1, which in turn induces the upregulation of Bdnf and Creb1. The same effect was seen in the hippocampus of mice. Lp-EV treatment in mice during the stress treatment (chronic restraint stress, CRST) phase increased expression of Bdnf1, Bdnf4, and Nt4/5. Also, Lp-EV injection at each stress session blocked the stress-induced decreased expression of proBDNF. Behavioral tests showed that mice treated with Lp-EV blocked stress-induced increased immobility and increased sociability.

Similar results were also observed in the study by Kwon et al. (2023a). Lacticaseibacillus paracasei-derived EVs (Lpc-EV) treatment counteracted GC-induced decreased expression of Bdnf, Nt3, Ngf, and TrkB. Knockdown of Mecp2 by siRNA inhibited the Lpc-EV-induced recovery of Bdnf, Nt4/5, TrkB, p53, Mkp1, and Fkbp5 expression induced by GC. Microarray data comparing gene expression in GC-treated HT-22 cells versus GC+Lpc-EV-treated cells showed that GC decreased stress-related MAPK pathways and neuronal cell death regulation, but Lpc-EV treatment reversed these alterations. These results demonstrate that Lpc-EV modulates GC-induced neurotrophic factor expression changes through Mecp2 regulation and affects stress response and epigenetic modification pathways via specific gene clusters. Similar trends of genetic changes were seen in CRST mice. In the results of the social interaction test, CRST mice exhibited reduced social interaction, in addition to increased immobility in the tail suspension test and the forced swim test. However, Lpc-EV treatment after stress partially reversed these changes.  In conclusion, these findings demonstrate that Lp-EV and Lpc-EV directly act on neuronal cells and mediate the antidepressant effects. Additionally, Lp-EV and Lpc-EV cargo components can effectively mitigate stress-induced changes in gene expression and depressive behaviors, highlighting their potential as therapeutic agents for stress-related disorders (Table 2).

Table 2. Potential as an antidepressant of PEVs

CSSPBQ_2024_v44n6_1252_8_t0001.png 이미지

PEVs, probiotics-derived extracellular vesicles; BDNF, brain-derived neurotrophic factor.

Possibility as a Treatment for Alzheimer’s Disease

Amyloid-beta (Aβ) appears to play an important role in Alzheimer’s disease. An imbalance of Aβ production and clearance induces Aβ accumulation, which can be continued to Alzheimer’s disease.  Treatment with Aβ42 in HT-22 cells downregulated the expression of Bdnf, Nt3, Nt4/5, Ngf, TrkB, and Mecp2, but Lpc-EV blocked these effects (Kwon et al., 2023b). Through siRNA-mediated knockdown, it was demonstrated that the upregulation of Bdnf, Nt3, Nt4/5, and TrkB by Lpc-EV was mediated by MeCP2 and Sirt1. These tendencies were analogous to those observed in Tg-APP/PS1 mice. In the hippocampus of these mice, the expression of Bdnf, Nt4/5, TrkB, Mecp2, Creb1, Sirt1, Sirt5, and Sirt7 was downregulated, whereas the expression of Hdac2, G9a, Setdb1, and Suv39h1 was upregulated. In contrast, when treated with Lpc-EV, the expression of Bdnf, Nt4/5, TrkB, Mecp2, Creb1, Sirt1, Sirt5, and Sirt7 was upregulated, whereas the expression of Hdac2, G9a, Setdb1, and Suv39h1 was downregulated. Furthermore, Lpc-EV treatment restored the downregulated expression of MeCP2 and Sirt1 proteins in the hippocampal neurons of Tg-APP/PS1 mice. Lpc-EV suppressed gliosis in the brains of Tg-APP/PS1 mice. In several behavioral tests, including the novel object recognition (NOR) test, water maze test, and passive avoidance (PA) test, the results revealed that Tg-APP/PS1 mice treated with Lpc-EV exhibited improved performance in object recognition and retention memory in NOR, as well as enhanced retention memory for shock-associated stimuli in the PA test. In conclusion, Lpc-EV induces MeCP2- and Sirt1-dependent upregulation of Bdnf, Nt3, Nt4/5, TrkB, Mmp-2, and Mmp-9, and epigenetic modification is a critical mechanism by which Lpc-EV alleviates Alzheimer’s disease-like pathology in Tg-APP/PS1 mice (Table 3).

Table 3. Possibility as a treatment for Alzheimer’s disease of PEVs

Conclusion and Prospect

EVs can be used as a potential treatment in health and disease because they can interact with host cells and deliver long-distance molecules to neighboring bacteria and host cells (Mandelbaum et al., 2023). Over the past few years, awareness of PEVs as promising therapeutic sources has been growing rapidly (Krzyżek et al., 2023). The evidence collated in this review suggests that PEVs might improve cognitive functioning in depression and Alzheimer’s disease via several mechanisms. Although PEVs can improve mental health and psychological function, they can be offered as new medicines for common mental disorders, some challenges and limitations should be addressed.

First, considering that bacterial EVs contain proteins, peptides, carbohydrates, lipids, nucleic acids, and bacterial metabolites (Yang et al., 2018), the bioactive components in PEVs should include some of these components. Therefore, the characterization of which substances will be included in PEVs and cause a transcriptional reaction must be made. Second, in some papers, PEVs regulate the expression of epigenetic factors. Considering that epigenetic factors can serve as the basic regulators of chromosome structures and the transcription of numerous genes, PEVs-induced changes in the epigenetic regulation of genes likely have genome-wide effects (Kwon et al., 2023a). Given the massive genome-wide effects of PEVs, bioactive components in PEVs might drive multiple arrays of signaling events to restore a homeostatic ability. Third is the lack of uniform standards for the separation, purification, characterization, storage, and quality control of PEVs. Due to the unique properties of PEVs, their separation and purification methods may not completely imitate the manufacturing process. Finally, although the safety of orally administered PEVs has been verified through animal experiments, their safety and biocompatibility with other nasogastric pathways must be comprehensively evaluated. The importance and potential application of PEVs in human health are not yet widely recognized. More clinical studies are necessary to determine the clinical significance of the effects and their bioequivalence or superiority against current treatments (Ansari et al., 2020).

In recent years, immunotherapy has emerged as an effective treatment strategy, and nanoparticle-mediated biotherapy has been reported to synergize with immunotherapy to improve response rates, resulting in better clinical outcomes (Zhang and Zhang, 2020). PEVs are attractive due to their unique advantages and therapeutic potential, especially in regulating immune responses to fight diseases. Therefore, future in-depth investigation needs to be undertaken to solve the above problems and apply them to biotherapeutics.

Conflicts of Interest

The authors declare no potential conflicts of interest.

Acknowledgements

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (NRF-2020R1A2C1010010).

Author Contributions

Conceptualization: Baek J, Kang SS. Data curation: Lee S, Lee J. Formal analysis: Park J. Methodology: Choi E. Software: Park J, Choi E. Validation: Lee S, Lee J. Investigation: Baek J. Writing - original draft: Baek J, Lee S, Lee J, Park J, Choi E, Kang SS. Writing - review & editing: Baek J, Lee S, Lee J, Park J, Choi E, Kang SS.

Ethics Approval

This article does not require IRB/IACUC approval because there are no human and animal participants.

References

  1. Abdul-Aziz MA, Cooper A, Weyrich LS. 2016. Exploring relationships between host genome and microbiome: New insights from genome-wide association studies. Front Microbiol 7:1611. 
  2. Ailioaie LM, Litscher G. 2021. Probiotics, photobiomodulation, and disease management: Controversies and challenges. Int J Mol Sci 22:4942. 
  3. Amirani E, Milajerdi A, Mirzaei H, Jamilian H, Mansournia MA, Hallajzadeh J, Ghaderi A. 2020. The effects of probiotic supplementation on mental health, biomarkers of inflammation and oxidative stress in patients with psychiatric disorders: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Med 49:102361. 
  4. Ansari F, Pourjafar H, Tabrizi A, Homayouni A. 2020. The effects of probiotics and prebiotics on mental disorders: A review on depression, anxiety, alzheimer, and autism spectrum disorders. Curr Pharm Biotechnol 21:555-565. 
  5. Baker MT, Lu P, Parrella JA, Leggette HR. 2022. Consumer acceptance toward functional foods: A scoping review. Int J Environ Res Public Health 19:1217. 
  6. Balthazar CF, Guimaraes JF, Coutinho NM, Pimentel TC, Ranadheera CS, Santillo A, Albenzio M, Cruz AG, Sant'Ana AS. 2022. The future of functional food: Emerging technologies application on prebiotics, probiotics and postbiotics. Compr Rev Food Sci Food Saf 21:2560-2586. 
  7. Barros CP, Guimaraes JT, Esmerino EA, Duarte MCK, Silva MC, Silva R, Ferreira BM, Sant'Ana AS, Freitas MQ, Cruz AG. 2020. Paraprobiotics and postbiotics: Concepts and potential applications in dairy products. Curr Opin Food Sci 32:1-8. 
  8. Begum PS, Madhavi G, Rajagopal S, Viswanath B, Razak MA, Venkataratnamma V. 2017. Probiotics as functional foods: Potential effects on human health and its impact on neurological diseases. Int J Nutr Pharmacol Neurol Dis 7:23-33. 
  9. Behzadi E, Hosseini HM, Fooladi AAI. 2017. The inhibitory impacts of Lactobacillus rhamnosus GG-derived extracellular vesicles on the growth of hepatic cancer cells. Micorb Pathog 110:1-6. 
  10. Bistas KG, Tabet JP. 2023. The benefits of prebiotics and probiotics on mental health. Cureus 15:e43217.
  11. Bleibel L, Dziomba S, Waleron KF, Kowalczyk E, Karbownik MS. 2023. Deciphering psychobiotics' mechanism of action: Bacterial extracellular vesicles in the spotlight. Front Microbiol 14:1211447. 
  12. Bose S, Aggarwal S, Singh DV, Acharya N. 2020. Extracellular vesicles: An emerging platform in Gram-positive bacteria. Microb Cell 7:312-322. 
  13. Brown L, Wolf JM, Prados-Rosales R, Casadevall A. 2015. Through the wall: Extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi. Nat Rev Microbiol 13:620-630. 
  14. Capurso L. 2019. Thirty years of Lactobacillus rhamnosus GG: A review. J Clin Gastroenterol 53:S1-S41. 
  15. Castellano P, Perez Ibarreche M, Blanco Massani M, Fontana C, Vignolo GM. 2017. Strategies for pathogen biocontrol using lactic acid bacteria and their metabolites: A focus on meat ecosystems and industrial environments. Microorganisms 5:38. 
  16. Champagne-Jorgensen K, Mian MF, McVey Neufeld KA, Stanisz AM, Bienenstock J. 2021. Membrane vesicles of Lacticaseibacillus rhamnosus JB-1 contain immunomodulatory lipoteichoic acid and are endocytosed by intestinal epithelial cells. Sci Rep 11:13756. 
  17. Chaudhari A, Dwivedi MK. 2022. The concept of probiotics, prebiotics, postbiotics, synbiotics, nutribiotics, and pharmabiotics. In Probiotics in the prevention and management of human diseases: A scientific perspective. Dwivedi MK, Amaresan N, Sankaranarayanan A, Kemp EH (ed). Academic Press, Cambridge, MA, USA. pp 1-11. 
  18. Choi J, Kim YK, Han PL. 2019. Extracellular vesicles derived from Lactobacillus plantarum increase BDNF expression in cultured hippocampal neurons and produce antidepressant-like effects in mice. Exp Neurobiol 28:158-171. 
  19. Choi JH, Moon CM, Shin TS, Kim EK, McDowell A, Jo MK, Joo YH, Kim SE, Jung HK, Shim KN. 2020. Lactobacillus paracasei-derived extracellular vesicles attenuate the intestinal inflammatory response by augmenting the endoplasmic reticulum stress pathway. Exp Mol Med 52:423-437. 
  20. Clapp M, Aurora N, Herrera L, Bhatia M, Wilen E, Wakefield S. 2017. Gut microbiota's effect on mental health: The gutbrain axis. Clin Pract 7:987. 
  21. Collado MC, Vinderola G, Salminen S. 2019. Postbiotics: Facts and open questions. A position paper on the need for a consensus definition. Benef Microbes 10:711-719. 
  22. Gambaro E, Gramaglia C, Baldon G, Chirico E, Martelli M, Renolfi A, Zeppegno P. 2020. "Gut-brain axis": Review of the role of the probiotics in anxiety and depressive disorders. Brain Behav 10:e01803. 
  23. Gamm L, Stone S, Pittman S. 2010. Mental health and mental disorders: A rural challenge: A literature review. Rural Healthy People 2:97-114. 
  24. Gandham S, Su X, Wood J, Nocera AL, Alli SC, Milane L, Zimmerman A, Amiji M, Ivanov AR. 2020. Technologies and standardization in research on extracellular vesicles. Trends Biotechnol 38:1066-1098. 
  25. Goralczyk-Binkowska A, Szmajda-Krygier D, Kozlowska E. 2022. The microbiota-gut-brain axis in psychiatric disorders. Int J Mol Sci 23:11245. 
  26. Guo C, Bai Y, Li P, He K. 2024. The emerging roles of microbiota-derived extracellular vesicles in psychiatric disorders. Front Microbiol 15:1383199. 
  27. Hao H, Zhang X, Tong L, Liu Q, Liang X, Bu Y, Gong P, Liu T, Zhang L, Xia Y, Ai L, Yi H. 2021. Effect of extracellular vesicles derived from Lactobacillus plantarum Q7 on gut microbiota and ulcerative colitis in mice. Front Immunol 12: 777147. 
  28. Hernandez-Granados MJ, Franco-Robles E. 2020. Postbiotics in human health: Possible new functional ingredients? Food Res Int 137:109660. 
  29. Hossain MM, Tasnim S, Sultana A, Faizah F, Mazumder H, Zou L, Mckyer ELJ, Ahmed HU, Ma P. 2020. Epidemiology of mental health problems in COVID-19: A review. F1000Res 9:636. 
  30. Hosseini-Giv N, Basas A, Hicks C, El-Omar E, El-Assaad F, Hosseini-Beheshti E. 2022. Bacterial extracellular vesicles and their novel therapeutic applications in health and cancer. Front Cell Infect Microbiol 12:962216. 
  31. Hu R, Lin H, Wang M, Zhao Y, Liu H, Min Y, Yang X, Gao Y, Yang M. 2021. Lactobacillus reuteri-derived extracellular vesicles maintain intestinal immune homeostasis against lipopolysaccharide-induced inflammatory responses in broilers. J Anim Sci Biotechnol 12:25. 
  32. Jastrzab R, Graczyk D, Siedlecki P. 2021. Molecular and cellular mechanisms influenced by postbiotics. Int J Mol Sci 22:13475. 
  33. Ji J, Jin W, Liu SJ, Jiao Z, Li X. 2023. Probiotics, prebiotics, and postbiotics in health and disease. MedComm 4:e420. 
  34. Johnson D, Letchumanan V, Thum CC, Thurairajasingam S, Lee LH. 2023. A microbial-based approach to mental health: The potential of probiotics in the treatment of depression. Nutrients 15:1382. 
  35. Kameli N, Dragojlovic-Kerkache A, Savelkoul P, Stassen FR. 2021. Plant-derived extracellular vesicles: Current findings, challenges, and future applications. Membranes 11:411. 
  36. Kim JH, Jeun EJ, Hong CP, Kim SH, Jang MS, Lee EJ, Moon SJ, Yun CH, Im SH, Jeong SG, Park BY, Kim KT, Seoh JY, Kim YK, Oh SJ, Ham JS, Yang BG, Jang MH. 2016. Extracellular vesicle-derived protein from Bifidobacterium longum alleviates food allergy through mast cell suppression. J Allergy Clin Immunol 137:507-516.E8. 
  37. Kim MH, Choi SJ, Choi HI, Choi JP, Park HK, Kim EK, Kim MJ, Moon BS, Min T, Rho M, Cho YJ, Yang S, Kim YK, Kim YY, Pyun BY. 2018. Lactobacillus plantarum-derived extracellular vesicles protect atopic dermatitis induced by Staphylococcus aureus-derived extracellular vesicles. Allergy Asthma Immunol Res 10:516-532. 
  38. Kong L, Zhang D, Huang S, Lai J, Lu L, Zhang J, Hu S. 2023. Extracellular vesicles in mental disorders: A state-of-art review. Int J Biol Sci 19:1094-1109. 
  39. Krzyzek P, Marinacci B, Vitale I, Grande R. 2023. Extracellular vesicles of probiotics: Shedding light on the biological activity and future applications. Pharmaceutics 15:522. 
  40. Kwon H, Lee EH, Choi J, Park JY, Kim YK, Han PL. 2023a. Extracellular vesicles released by Lactobacillus paracasei mitigate stress-induced transcriptional changes and depression-like behavior in mice. Exp Neurobiol 32:328-342. 
  41. Kwon H, Lee EH, Park SY, Park JY, Hong JH, Kim EK, Shin TS, Kim YK, Han PL. 2023b. Lactobacillus-derived extracellular vesicles counteract Aβ42-induced abnormal transcriptional changes through the upregulation of MeCP2 and Sirt1 and improve Aβ pathology in Tg-APP/PS1 mice. Exp Mol Med 55:2067-2082. 
  42. Lee BH, Chen YZ, Shen TL, Pan TM, Hsu WH. 2023. Proteomic characterization of extracellular vesicles derived from lactic acid bacteria. Food Chem 427:136685. 
  43. Lee KE, Kim JK, Han SK, Lee DY, Lee HJ, Yim SV, Kim DH. 2020. The extracellular vesicle of gut microbial paenalcaligenes hominis is a risk factor for vagus nerve-mediated cognitive impairment. Microbiome 8:107. 
  44. Lee SH, Ow DSW, Tay PKR, Chen D, Chow PS, Yang YY, Liu SQ, Heng D. 2024. A formulation platform for incorporating live probiotics into different food matrices. J Food Eng 378:112113. 
  45. Li Y, Gui Y, Zhao M, Chen X, Li H, Tian C, Zhao H, Jiang C, Xu P, Zhang S, Ye S, Huang M. 2023. The roles of extracellular vesicles in major depressive disorder. Front Psychiatry 14:1138110. 
  46. Liang B, Xing D. 2023. The current and future perspectives of postbiotics. Probiotics Antimicrob Proteins 15:1626-1643. 
  47. Lillo-Perez S, Guerra-Valle M, Orellana-Palma P, Petzold G. 2021. Probiotics in fruit and vegetable matrices: Opportunities for nondairy consumers. LWT-Food Sci Technol 151:112106. 
  48. Liu C, Ma N, Feng Y, Zhou M, Li H, Zhang X, Ma X. 2023. From probiotics to postbiotics: Concepts and applications. Anim Res One Health 1:92-114. 
  49. Liu H, Geng Z, Su J. 2022. Engineered mammalian and bacterial extracellular vesicles as promising nanocarriers for targeted therapy. Extracell Vesicles Circ Nucleic Acids 3:63-86. 
  50. Ma L, Wang J, Zhang D, Huang Y, Huang L, Wang P, Qian H, Li X, Terryn HA, Mol JM. 2021. Dual-action self-healing protective coatings with photothermal responsive corrosion inhibitor nanocontainers. Chem Eng J 404:127118. 
  51. Mandelbaum N, Zhang L, Carasso S, Ziv T, Lifshiz-Simon S, Davidovich I, Luz I, Berinstein E, Gefen T, Cooks T, Talmon Y, Balskus EP, Geva-Zatorsky N. 2023. Extracellular vesicles of the Gram-positive gut symbiont Bifidobacterium longum induce immune-modulatory, anti-inflammatory effects. npj Biofilms Microbiomes 9:30. 
  52. Miranda M, Morici JF, Zanoni MB, Bekinschtein P. 2019. Brain-derived neurotrophic factor: A key molecule for memory in the healthy and the pathological brain. Front Cell Neurosci 13:363. 
  53. Miyoshi Y, Saika A, Nagatake T, Matsunaga A, Kunisawa J, Katakura Y, Yamasaki-Yashiki S. 2021. Mechanisms underlying enhanced IgA production in Peyer's patch cells by membrane vesicles derived from Lactobacillus sakei. Biosci Biotechnol Biochem 85:1536-1545. 
  54. Morishita M, Horita M, Higuchi A, Marui M, Katsumi H, Yamamoto A. 2021. Characterizing different probiotic-derived extracellular vesicles as a novel adjuvant for immunotherapy. Mol Pharm 18:1080-1092. 
  55. Mulcahy LA, Pink RC, Carter DRF. 2014. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles 3:24641. 
  56. Munoz-Echeverri LM, Benavides-Lopez S, Geiger O, Trujillo-Roldan MA, Valdez-Cruz NA. 2024. Bacterial extracellular vesicles: Biotechnological perspective for enhanced productivity. World J Microbiol Biotechnol 40:174. 
  57. Nataraj BH, Ali SA, Behare PV, Yadav H. 2020. Postbiotics-parabiotics: The new horizons in microbial biotherapy and functional foods. Microb Cell Fact 19:168. 
  58. O'Brien J, Hayder H, Zayed Y, Peng C. 2018. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol 9:402. 
  59. Palanivelu J, Thanigaivel S, Vickram S, Dey N, Mihaylova D, Desseva I. 2022. Probiotics in functional foods: Survival assessment and approaches for improved viability. Appl Sci 12:455. 
  60. Park JH, Kim KW. 2011. A review of the epidemiology of depression in Korea. J Korean Med Assoc 54:362-369. 
  61. Pique N, Berlanga M, Minana-Galbis D. 2019. Health benefits of heat-killed (tyndallized) probiotics: An overview. Int J Mol Sci 20:2534. 
  62. Roy D, Tripathy S, Kar SK, Sharma N, Verma SK, Kaushal V. 2020. Study of knowledge, attitude, anxiety & perceived mental healthcare need in Indian population during COVID-19 pandemic. Asian J Psychiatry 51:102083. 
  63. Salminen S, Collado MC, Endo A, Hill C, Lebeer S, Quigley EMM, Sanders ME, Shamir R, Swann JR, Szajewska H, Vinderola G. 2021. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol 18:649-667. 
  64. Shi Y, Meng L, Zhang C, Zhang F, Fang Y. 2022. Extracellular vesicles of Lacticaseibacillus paracasei PC-H1 induce colorectal cancer cells apoptosis via PDK1/AKT/Bcl-2 signaling pathway. Microbiol Res 255:126921. 
  65. Silva AM, Ribeiro CT, Bernardino RL, Jarak I, Carvalho RA, Pereira-Sampaio MA, de Souza DB, Alves MG, Oliveira PF. 2022. Stress hormone corticosterone controls metabolic mitochondrial performance and inflammatory signaling of in vitro cultured sertoli cells. Biomedicines 10:2331. 
  66. Son SH, Yang SJ, Jeon HL, Yu HS, Lee NK, Park YS, Paik HD. 2018. Antioxidant and immunostimulatory effect of potential probiotic Lactobacillus paraplantarum SC61 isolated from Korean traditional fermented food, jangajji. Microb Pathog 125:486-492. 
  67. Suri K, D'Souza A, Huang D, Bhavsar A, Amiji M. 2023. Bacterial extracellular vesicle applications in cancer immunotherapy. Bioact Mater 22:551-566. 
  68. Tong J, Satyanarayanan SK, Su H. 2020. Nutraceuticals and probiotics in the management of psychiatric and neurological disorders: A focus on microbiota-gut-brain-immune axis. Brain Behav Immun 90:403-419. 
  69. Tong L, Zhang X, Hao H, Liu Q, Zhou Z, Liang X, Liu T, Gong P, Zhang L, Zhai Z. 2021. Lactobacillus rhamnosus GG derived extracellular vesicles modulate gut microbiota and attenuate inflammatory in DSS-induced colitis mice. Nutrients 13:3319. 
  70. Wang X, Zhang P, Zhang X. 2021. Probiotics regulate gut microbiota: An effective method to improve immunity. Molecules 26:6076. 
  71. Wieers G, Belkhir L, Enaud R, Leclercq S, Philippart de Foy JM, Dequenne I, de Timary P, Cani PD. 2020. How probiotics affect the microbiota. Front Cell Infect Microbiol 9:454. 
  72. World Health Organization [WHO]. 2022. World mental health report. Transforming mental health for all. Available from: https://iris.who.int/bitstream/handle/10665/356119/9789240049338-eng.pdf?sequence=1. Accessed at Jul 17, 2024. 
  73. Xie J, Li Q, Nie S. 2023. Bacterial extracellular vesicles: An emerging postbiotic. Trends Food Sci Technol 143:104275. 
  74. Xiong RG, Li J, Cheng J, Zhou DD, Wu SX, Huang SY, Saimaiti A, Yang ZJ, Gan RY, Li HB. 2023. The role of gut microbiota in anxiety, depression, and other mental disorders as well as the protective effects of dietary components. Nutrients 15:3258. 
  75. Yan R, Zeng X, Shen J, Wu Z, Guo Y, Du Q, Tu M, Pan D. 2024. New clues for postbiotics to improve host health: A review from the perspective of function and mechanisms. J Sci Food Agric 104:6376-6387. 
  76. Yang J, Kim EK, McDowell A, Kim YK. 2018. Microbe-derived extracellular vesicles as a smart drug delivery system. Transl Clin Pharmacol 26:103-110. 
  77. Yang J, Shin TS, Kim JS, Jee YK, Kim YK. 2022. A new horizon of precision medicine: Combination of the microbiome and extracellular vesicles. Exp Mol Med 54:466-482. 
  78. Yesilyurt N, Yilmaz B, Agagunduz D, Capasso R. 2021. Involvement of probiotics and postbiotics in the immune system modulation. Biologics 1:89-110. 
  79. Zagorska A, Marcinkowska M, Jamrozik M, Wisniowska B, Pasko P. 2020. From probiotics to psychobiotics: The gut-brain axis in psychiatric disorders. Benef Microbes 11:717-732. 
  80. Zhang Y, Zhang Z. 2020. The history and advances in cancer immunotherapy: Understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol 17:807-821. 
  81. Zhuang X, Xiang X, Grizzle W, Sun D, Zhang S, Axtell RC, Ju S, Mu J, Zhang L, Steinman L, Miller D, Zhang HG. 2011. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther 19:1769-1779. 
  82. Zielinska D, Sionek B, Kolozyn-Krajewska D. 2018. Safety of probiotics. In Diet, microbiome and health. Holban AM, Grumezescu AM (ed). Academic Press, Cambridge, MA, USA. pp 131-161. 
  83. Zolkiewicz J, Marzec A, Ruszczynski M, Feleszko W. 2020. Postbiotics: A step beyond pre- and probiotics. Nutrients 12:2189.